Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Odin

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Scottish Medical Journal|September 25, 2012
Duration of L-dopa and dopamine agonist monotherapy in Parkinson's diseaseT Nissen, E J Newman, K A Grosset, et al.
Annals of Neurology|February 1, 1994
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's diseaseO Lindvall, G Sawle, H Widner, et al.
Annals of Neurology|February 1, 1992
Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implantsO Lindvall, H Widner, S Rehncrona, et al.
Nuklearmedizin. Nuclear Medicine|February 26, 2003
[[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophyG Berding, Th Brücke, P Odin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1995
Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled studyL Ostergaard, L Werdelin, P Odin, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 7, 2020
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson's disease patients: an European multicentre surveyA Rizos, A Sauerbier, C Falup-Pecurariu, et al.
Neuroreport|August 10, 2001
Intermuscular coherence in Parkinson's disease: relationship to bradykinesiaP Brown, J Marsden, L Defebvre, et al.
Parkinsonism & Related Disorders|October 2, 2014
Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: an international multicenter studyA Rizos, P Martinez-Martin, P Odin, et al.
Parkinsonism & Related Disorders|August 3, 2015
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion programP Odin, K Ray Chaudhuri, J T Slevin, et al.
Der Nervenarzt|January 23, 2008
[Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement]C Trenkwalder, S Boesch, A Ceballos-Baumann, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Scottish Medical Journal|September 25, 2012
Duration of L-dopa and dopamine agonist monotherapy in Parkinson's diseaseT Nissen, E J Newman, K A Grosset, et al.
Annals of Neurology|February 1, 1994
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's diseaseO Lindvall, G Sawle, H Widner, et al.
Annals of Neurology|February 1, 1992
Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implantsO Lindvall, H Widner, S Rehncrona, et al.
Nuklearmedizin. Nuclear Medicine|February 26, 2003
[[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophyG Berding, Th Brücke, P Odin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1995
Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled studyL Ostergaard, L Werdelin, P Odin, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 7, 2020
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson's disease patients: an European multicentre surveyA Rizos, A Sauerbier, C Falup-Pecurariu, et al.
Neuroreport|August 10, 2001
Intermuscular coherence in Parkinson's disease: relationship to bradykinesiaP Brown, J Marsden, L Defebvre, et al.
Parkinsonism & Related Disorders|October 2, 2014
Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: an international multicenter studyA Rizos, P Martinez-Martin, P Odin, et al.
Parkinsonism & Related Disorders|August 3, 2015
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion programP Odin, K Ray Chaudhuri, J T Slevin, et al.
Der Nervenarzt|January 23, 2008
[Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement]C Trenkwalder, S Boesch, A Ceballos-Baumann, et al.
Pageof 10